Across TCGA pan-cancer cohorts, LINC01966 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC01966’s most consistent transcriptional readouts.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LINC01966 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01966 is over-expressed in tumor.
LIHC are the cancer types where LINC01966 tumor–normal differential expression is most reproducible.